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ABSTRACT
Polyneuropathy, organomegaly, endocrinopathy,
M-protein and skin changes (POEMS) syndrome
is a rare paraneoplastic disorder associated with
an underlying plasma cell dyscrasia and
multiorgan failure. POEMS syndrome is
potentially fatal and adversely affects quality of
life. Oedema is common with many patients
affected by pleural effusions, ascites and lower
limb oedema. Bioelectrical impedance vector
analysis (BIVA) is a non-invasive assessment tool,
which enables rapid bedside assessments of
nutrition and hydration. This paper describes the
use of sequential BIVA assessments to evaluate
the response to diuretic therapy in a woman
aged 52 years with POEMS syndrome. This case
illustrates the potential to use BIVA to conduct
longitudinal assessments of hydration status. This
provides opportunities for further research using
BIVA to monitor hydration and response to
interventions. This may be useful in specific
situations, for example at the end of life.
INTRODUCTION
Polyneuropathy, organomegaly, endocrino-
pathy, M-protein and skin changes
(POEMS) syndrome is a rare paraneoplas-
tic disorder associated with an underlying
plasma cell dyscrasia and multiorgan
failure.1 The pathogenesis of POEMS syn-
drome is likely caused by overproduction
of vascular endothelial growth factor
(VEGF).2 POEMS syndrome is potentially
fatal and adversely affects quality of life.
Oedema is common with many patients
affected by pleural effusions and ascites.1 2
There is limited evidence to determine
the association between hydration and
symptoms in advanced cancer.3 Physical
examination has a low sensitivity and
specificity for identifying fluid deficit
and, biochemical methods show little asso-
ciation with hydration status.3 4 There is
no routine hydration assessment method
for patients with advanced cancer. The evi-
dence for the efficacy of clinically assisted
hydration (CAH) in advanced cancer is
limited, conflicting and inconclusive. The
subject of hydration is extremely important
to patients and caregivers; there is concern
about the risk of harm to patients through
the use or non-use of CAH.3
Bioelectrical impedance vector analysis
(BIVA) is a non-invasive, validated body
composition assessment method, which
may be useful in the assessment of hydra-
tion.5 To date, there are no published
reports about the utility of BIVA in
POEMS syndrome.
CASE HISTORY
This case describes the use of BIVA in a
woman aged 52 years with POEMS syn-
drome. She had a history of two autolo-
gous stem cell transplants, renal
impairment and recurrent lower limb and
abdominal oedema. Oedema was a cause
of great discomfort and had adversely
affected her mobility. She was referred to
the specialist palliative care team for
symptom management and fluid assess-
ment using BIVA. Following the baseline
assessment, she received 40 mg of oral
furosemide daily in combination with
advice about fluid restriction. Two
further BIVA assessments were conducted
at weekly intervals following the com-
mencement of diuretic therapy to assess
the response to diuretic therapy. A clin-
ical evaluation of peripheral oedema
(upper and lower limbs) was also con-
ducted during these assessments.
BIOELECTRICAL IMPEDANCE VECTOR
ANALYSIS (BIVA)
Bioimpedance analysis involves a tetrapo-
lar technique to deliver a single-frequency
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electrical current of 50 kHz. The technique works on
the principle that fluid and cellular structures will
provide different levels of resistance to an electrical
current as it passes through the human body.
Bioimpedance provides the following direct measure-
ments: resistance (R) assessing cellular hydration,
reactance (Xc) assessing tissue integrity and phase
angle (PA), which is reported to be a useful indicator
of health and prognosis.5 Bioimpedance analysis was
conducted using the EFG-3 ElectroFluidGraph Vector
Impedance Analyser (Akern) in line with methods and
recommendations described elsewhere.5 Regression
equations of the manufacturer (Akern BodyGram Pro
3.0) were used to calculate total body water (TBW),
intracellular water (ICW) and extracellular water
(ECW).6 These validated equations were derived from
previous research.7
BIVA enables interpretation of bioimpedance data,
which is independent of regression equations and
body weight. To establish BIVA, the direct impedance
measurements (R and Xc) were plotted as a point
(bivariate random vector) on a probability graph (RXc
graph); this represented the sex-specific and race-
specific tolerance intervals of a non-cancer reference
population used for the analysis (figure 1).8
RESULTS
At baseline, BIVA demonstrated the participant’s
overall body composition was just outside the normal
ellipse 50th centile and did not suggest fluid overload
(figure 1). Following diuretic therapy, the subsequent
assessments demonstrated a reduction in hydration
volume. This corresponded with weight loss and a
reduction in clinically detectable oedema. Throughout
the assessments, TBW was low relative to body weight
(table 1) and ECW was high relative to TBW.
DISCUSSION
Main findings
BIVA demonstrated a reduction in hydration volume
following the intervention (diuretic therapy and fluid
restriction). This corresponded clinically with weight
loss and a reduction in clinically detectable oedema.
Strengths
To our knowledge, this is the first study to use BIVA to
evaluate hydration in POEMS syndrome. Furthermore,
the evaluation of longitudinal change in hydration in
POEMS syndrome using BIVA, following intervention
with diuretics, is novel. The advantage of BIVA is that
it allows information to be obtained simultaneously
about changes in tissue hydration or soft tissue mass,
independent of regression equations, or body weight.
This allows for accurate interpretation of BIVA read-
ings even if patients are at extremes of weight or
volume distribution.
Significance of the findings and comparison with
previous studies
The correlations between hydration change, body
weight and observable oedema are consistent with
non-cancer studies using BIVA to measure hydration.9
The participant commented on the simplicity of the
BIVA method. Her experience is consistent with the
findings of our previous research using BIVA to evalu-
ate hydration in advanced cancer, which adds to the
evidence that the BIVA method is not burdensome in
palliative care.10
TBW was low relative to body weight; however,
ECW was high compared with TBW. This suggests an
imbalance of ECW:ICW ratio, which may be the
potential cause of the oedema. Although there was a
clinical reduction in weight and oedema, this was not
reflected by change in the ECW volume. The reason
for this is not clear; however, a potential explanation
may be that the bioimpedance regression equations
lack the sensitivity to detect small changes in fluid
volume.
Limitations
Bioimpedance regression equations are limited in
cancer owing to their reliance on physiological
assumptions (which include requirements about body
shape, the relationship between trunk and leg lengths,
soft tissue hydration level and fat fraction).5 Although
the equations have been validated against reference
methods with good accuracy, they may lack accuracy
in situations where basic assumptions of the bioimpe-
dance method are not met (eg, in cancer or at
Figure 1 Longitudinal change of hydration represented by the
BIVA RXc graph. The RXc graph method allows statistical
analysis of bivariate distributions of successive impedance
vectors of an individual relative to the 50%, 75% and 95%
tolerance ellipses of a non-cancer reference population. The
black dots represent the study assessments. The black arrow
demonstrates the linear trend of the assessments. BIVA,
bioelectrical impedance vector analysis; R, resistance; Xc,
reactance.
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extremes of body mass and hydration).5 The limita-
tions of regression equations are overcome by BIVA,
which is independent of the regression analysis and
body weight. We acknowledge that we are unable to
account for potential confounding factors, which may
have influenced hydration between assessments.
Furthermore, the relative under-representation of the
trunk by whole-body impedance limits our ability to
quantify or localise the oedema.5 Consequently, BIVA
should be interpreted with acknowledgement of the
clinical presentation of the individual.
Implications for practice
The properties of BIVA (non-invasive, safe, accurate
and painless) highlight its potential to assess hydration
in palliative care. BIVA could potentially be used to
measure hydration in specific clinical scenarios (eg,
bowel obstruction, vomiting and diarrhoea) or to
monitor the response to interventions (eg, CAH).9 In
cancer, BIVA has advantages over regression equa-
tions; however, the results should be interpreted care-
fully with knowledge of the clinical presentation of
the patient.
Research opportunities
In research, BIVA can be used to monitor hydration in
studies that evaluate the efficacy of CAH.
Furthermore, longitudinal hydration assessments
could be conducted at specific phases of illness (eg, to
examine the relationship between symptomatic
burden and clinical hydration states in the last hours
and days of life).
CONCLUSION
This case report highlights the potential to use BIVA
to monitor hydration states over time in response to
interventions. BIVA overcomes the limitations of
bioimpedance regression equations. More research is
needed to determine the potential of BIVA to improve
the evaluation and management of hydration states in
advanced cancer.
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